Skip to content
Medical Health Aged Care

Australian, international infectious disease and vaccine experts gather in Perth

Public Health Association of Australia < 1 min read

Over 600 leading health experts will gather in Perth this week for the Communicable Diseases and Immunisation Conference.

Starting from Monday, the conference will discuss topics ranging from progress towards the establishment of Australia’s Centre for Disease control, the latest evidence on emerging and new infectious disease threats in Australia, the latest vaccine technology, and how Australia can support neighbouring countries with their health needs.   

A special address by a senior World Health Organization official, Dr Kate O’Brien will also explore the challenges and future opportunities for immunisation and vaccination around the world. 

The full program is available here.

Hosted by the peak body Public Health Association of Australia, the conference at the Perth Convention and Exhibition Centre runs 19-21 June.

Media are invited to attend and cover the conference, and request interviews.

Footage and picture opportunities: Presentations about communicable diseases and immunisation; attendees gathering at conference

What: Communicable Diseases and Immunisation Conference 2023

When: Monday 19 June – Wednesday 21 June, 8:30am AWST – 5:30pm AWST

Where: Level 2, Perth Convention and Exhibition Centre

Who: Speakers include:

  • Australia’s Chief Medical Officer, Prof Paul Kelly, on the Centre for Disease Control, and other topics;
  • WHO Director, Immunisation, Vaccines and Biologicals, Dr Kate O'Brien;
  • Australia’s Ambassador for Regional Health Security, Dr Stephanie Williams, on regional health challenges and how Australia has responded;
  • WA Parliamentary Secretary for Health, Simon Millman MLA

 

For media enquiries or to register for an in-person or virtual media pass (recordings valid for three months), please contact:

For further information/comment:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected]


Contact details:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected]

Media

More from this category

  • General News, Medical Health Aged Care
  • 12/03/2026
  • 14:07
Parliament of Australia

Public hearing concerning the National Redress Scheme

TheJoint Standing Committee on Implementation of the National Redress Schemewill hold a public hearing in Canberra on Friday, 13 March 2026, for itsinquiry into the continuing operation of the Scheme. Committee Chair, Ms Jodie Belyea MP, said the Committee is grateful for the contributions made in support of the inquiry to date. ‘The National Redress Scheme plays a central role in Australia’s response to institutional child sexual abuse. It is an important program for a significant number of people. The Committee has received a substantial number of submissions in support of our current inquiry, and public hearings over the coming…

  • Energy, Medical Health Aged Care
  • 12/03/2026
  • 12:11
Sweltering Cities

The cost of keeping cool is making Australians sick: New report reveals millions forced to ration cooling during record heat

12 March 2026 Sweltering Cities has today released the findings of its 2026 Summer Survey, exposing a national health crisis driven by the rising cost of keeping cool. With data from more than 2,600 respondents across 766 postcodes, the report proves that for many Australians the high cost of staying cool is having serious physical and mental health impacts. The 2025/26 summer saw 68% of all respondents report feeling unwell due to heat. However, the survey reveals that this burden is falling most heavily on those already struggling with the cost of living. For renters and people with disabilities, the…

  • Medical Health Aged Care
  • 12/03/2026
  • 10:01
Monash University

Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and transport function, backed by an up to $22.4 million AUD Award from the Advanced Research Projects Agency for Health (ARPA-H). The researchers join ARPA-H’s GLIDE (Groundbreaking Lymphatic Interventions and Drug Exploration) program to transform how both primary lymphatic diseases and common chronic diseases are treated by developing innovative therapeutics that alleviate, repair or regenerate a dysfunctional lymphatic vascular system. Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, said the work…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.